Comparative Evaluation of Indirect Pulp Therapy in Young Permanent Teeth using Biodentine and Theracal: A Randomized Clinical Trial

Objective: In a tooth with deep dentinal caries; judicious removal of infected dentin and isolating affected dentin from oral fluids with suitable biocompatible material is called indirect pulp therapy (IPT). This randomized clinical trial was done to evaluate and compare the efficacy of Biodentine, Theracal LC and. Dycal as an indirect pulp capping agent in young permanent teeth. Study Design: IPT was performed in 60 young permanent molars with caries approaching pulp in 55 healthy children using Biodentine, Theracal and Dycal. A 2–3mm layer of GIC was placed over the intervening material followed by restoration of cavity with composite. Clinical and radiographic examinations were conducted at 3 weeks, 3 months, 6 months,12 months, 18 months and 24 months. The data was compared using chi-square test at a significance level of 0.05. Results: By end of 24 months ,54 teeth presented for follow up with overall success rate of 100% in Theracal, 94.44% in Biodentine, and 77.78% in Dycal. Overall success of Theracal was statistically significant in comparison to Biodentine and Dycal at 24 months follow up (p= 0.03)

Conclusions: Radiographic and clinical outcomes of Theracal and Biodentine suggest their use as an alternative material for IPT in young permanent molars with higher success.

Theracal LC; Biodentine; Tricalcium silicate; Indirect pulp therapy; Young permanent teeth

1. Stanley HR. Pulp capping: conserving the dental pulp—can it be done? Is it worth it?. Oral Surg Oral Med Oral Pathol;68(5):628-39. 1989.

2. Kidd EM. How ‘clean’ must a cavity be before restoration?.Caries Res;38(3):305-313. 2004.

3. Ranly DM, Garcia-Godoy F. Current and potential pulp therapies for primary and young permanent teeth. J Dent; 28(3):153-61. . 2000.

4. Makkar S, Kaur H, Aggarwal A, Vashisht R. A confocal laser scanning microscopic study evaluating the sealing ability of mineral trioxide aaggregate, Biodentine and a new pulp capping agent- Theracal. Dental Journal of Advance Studies;3(1):20-25.2015.

5. Garrocho-Rangel A, Quintana-Guevara K, Vázquez-Viera R, Arvizu-Rivera JM, Flores-Reyes H, Escobar-García DM, et al. Bioactive Tricalcium Silicate-based Dentin Substitute as an Indirect Pulp Capping Material for Primary Teeth: A 12-month Follow-up. Pediatr Dent;15;39(5):377-382.. 2017.

6. Taha NA, Abdulkhader SZ. Full Pulpotomy with Biodentine in Symptomatic Young Permanent Teeth with Carious Exposure. J Endod;44(6):932-937.2018.

7. Rajasekharan S, Martens LC, Cauwels RG, Verbeeck RM:Biodentine material characterstics and clinical applications: a review of the literature. Eur Arch Paediatr Dent;15(3):147-58. 2014.

8. Gandolfi MG, Siboni F, Prati C. Chemical–physical properties of Theracal, a novel light-curable MTA-like material for pulp capping. IntEndod J; 45(6):571-579. 2012.

9. Fontana M, Young D, Wolff M, Pitts NB, Longbottom C. Defining dental caries for 2010 and beyond. Dent Clin North Am; 54(3):423-440. 2010.

10. Barthel CR, Rosenkranz B, Leuenberg A, Roulet JF. Pulp Capping of Carious Exposures: Treatment Outcome after 5 and 10 Years: A Retrospective Study. J Endod;26:525-528. 2000.

11. Bjorndal L, Reit C, Bruun G, Markvart M, Kjaeldgaard M.Nasman P et al.Treatment of deep caries lesions in adults: randomized clinical trials comparing stepwise vs. direct complete excavation, and direct pulp capping vs. partial pulpotomy. Eur J Oral Sci; 118:290-297.2010.

12. Dammaschke T, Leidinger J, Schafer E: Long-term evaluation of direct pulp capping—treatment outcomes over an average period of 6.1 years. Clin Oral Investig;14(5):559-567. 2010.

13. Banerjee A, Watson T, Kidd EA. Dentine caries excavation: a review of current clinical techniques. Br Dent J;188:476-482. 2000.

14. Maltz M, Oliveira EF, Fontanella V, Carminatti G. Deep Caries Lesions after Incomplete Dentine Caries Removal: 40- Month Follow-Up Study. Caries Res;41(6):493-496. .2007.

15. Gruythuysen RJ, Van Strijp AJ, Wu MK. Long-term Survival of Indirect Pulp Treatment Performed in Primary and Permanent Teeth with Clinically Diagnosed Deep Carious Lesions. J Endod;36(9):1490-1493. 2010.

16. Bjorndal L, Larsen T, Thylstrup A. A clinical and microbiological study of deep carious lesions during stepwise excavation using long treatment intervals. Caries Res; 31(6): 411-417.1997.

17. Neves A,Coutinho E., De Munck, J, Van Meerbeek, B. Caries-removal effectiveness and minimal-invasiveness potential of caries-excavation techniques: a micro-CT investigation. J Dent;39(2):154-162.2011.

18. Hilton TJ. Keys to clinical success with pulp capping: a review of the literature. Oper Dent;34(5):615-25.2009.

19. Cox CF, Subay RK, Ostro E, Suzuki S, Suzuki SH. Tunnel defects in dentin bridges: their formation following direct pulp capping. Oper Dent; 21(1):4-11.1996.

20. Farhad A, MohammadiZ.Calcium hydroxide: a review. Int Dent J;55(5): 293-301.2005.

21. Leye Benoist F, Gaye NdiayeF, Kane AW, Benoist HM, Farge P. Evaluation of mineral trioxide aggregate (MTA) versus calcium hydroxide cement (Dycal) in the formation of a dentine bridge: a randomised controlled trial. Int Dent J; 62(1):33-9.2012.

22. Sultana R, Hossain M, Alam MS. Evaluation of clinical and radiological outcomes of mineral trioxide aggregate and calcium hydroxide as indirect pulp capping agents in the treatment of deep carious lesion of permanent teeth. Bangabandhu Sheikh Mujib Medical University J; 9:140-145. 2016.

23. Nirschl RF, Avery DR. Evaluation of a new pulp capping agent in indirect pulp therapy. ASDC J Dent Child;50(1):25-30. 1983.

24. Petrou MA, Alhamoui FA, Welk A, Altarabulsi MB, Alkilzy M, H Splieth C. A randomized clinical trial on the use of medical Portland cement, MTA and calcium hydroxide in indirect pulp treatment. Clin Oral Investig;18(5):1383-9. 2014.

25. Mathur VP, Dhillon JK, Logani A, Kalra G: Evaluation of indirect pulp capping using three different materials: A randomized control trial using cone-beam computed tomography. Indian J Dent Res; 27(6):623-629.2016.

26. Orhan AI, Oz FT, Ozcelik B, Orhan K. A clinical and microbiological comparative study of deep carious lesion treatment in deciduous and young permanent molars. Clin Oral Investig;12(4):369-78.2008.

27. Orhan AI, Oz FT, Orhan K. Pulp exposure occurrence and outcomes after 1-or 2-visit indirect pulp therapy vs complete caries removal in primary and permanent molars. Pediatr Dent; 32(4):347-55. 2010.

28. Maltz M, Alves LS, Jardim JJ, Moura Mdos S, de Oliveira EF.Incomplete caries removal in deep lesions: A 10-year prospective study. Am J Dent; 24(4):211-214.2011.

29. Zanini M, Sautier JM, Berdal A, Simon S: Biodentine induces immortalized murine pulp cell differentiation into odontoblast-like cells and stimulates biomineralization. J Endod;38(9):1220-6. 2012.

30. Hashem D, Mannocci F, Patel S, Manoharan A, Brown JE, Watson TF, ET AL.Clinical and radiographic assessment of the efficacy of calcium silicate indirect pulp capping: a randomized controlled clinical trial. J Dent Res;94(4):562-8. 2015.

31. Arandi NZ, Rabi T. TheraCal LC: From biochemical and bioactive properties to clinical applications. Int J Dent;34.846-53. 2018.

32. Camilleri J, Laurent P, About I. Hydration of biodentine, theracal LC, and a prototype tricalcium silicate-based dentin replacement material after pulp capping in entire tooth cultures. J Endod;40(11):1846–1854.2014.

33. Poggio C, Lombardini M, Colombo M, Beltrami R, Rindi S. Solubility and pH of direct pulp capping materials: a comparative study. Journal of Applied Biomaterials & Functional Materials;13(2):181-185.2015.

34. Yamamoto S, Han L, Noiri Y, Okiji T. Evaluation of the Ca ion release, pH and surface apatite formation of a prototype tricalcium silicate cement. Int Endod J;50(2):73-82. 2017.

35. Gandolfi MG, Siboni F, Botero T, Bossù M, Riccitiello F, Prati C. Calcium silicate and calcium hydroxide materials for pulp capping: biointeractivity, porosity, solubility and bioactivity of current formulations. J ApplBiomaterFunct Mater;13(1):43-60. 2015.